Market Signal Briefing

, /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired aTyr Pharma, Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025. aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate  

According to the complaint, defendants provided investors with material information concerning aTyr's Phase 3, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of intravenous Efzofitimod in patients with pulmonary sarcoidosis (EFZO-FIT). Defendants' statements included, among other things, aTyr's top executives' confidence in the forced taper approach of the Company's study design. Defendants allegedly made these statements while concealing the drug's capability to allow a patient to completely taper their steroid usage.

Plaintiff alleges that on September 15, 2025, aTyr hosted an investor call announcing that the EFZO-FIT study did not meet its primary endpoint. In pertinent part, defendants announced that the study did not meet the primary endpoint in change from baseline in mean daily OSC dose at week 48. Additionally, aTyr announced that the Company's next step was to engage with the FDA to determine a path forward, given the disappointing topline results. On this news, the price of aTyr's common stock declined from a closing price of $6.03 per share on September 12, 2025, to $1.02 per share on September 15, 2025, an 83.2% decline in a single day.

What Now: You may be eligible to participate in the class action against aTyr Pharma, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by December 8, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. 

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. 

To be notified if a class action against aTyr Pharma, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising.  Past results do not guarantee a similar outcome.  

www.robbinsllp.com

SOURCE Robbins LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Gerresheimer AG (OTCPK:GRRMY) Q3 2025 Earnings Call October 9, 2025 2:30 AM EDT

Company Participants

Guido Pickert - Head of Investor Relations
Dietmar Siemssen - CEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division
Wolf Lehmann - CFO & Member of the Management Board

Conference Call Participants

Edward Hall - Stifel, Nicolaus & Company, Incorporated, Research Division
Olivier Calvet - UBS Investment Bank, Research Division
David Adlington - JPMorgan Chase & Co, Research Division
Anna Snopkowski - KeyBanc Capital Markets Inc., Research Division

Presentation

Guido Pickert
Head of Investor Relations

Good morning, everyone, and welcome to our presentation of our preliminary Q3 2025 results. With us today are our CEO, Dietmar Siemssen; and our new CFO, Wolf Lehmann, who will lead you through our Q3 development and the financials. The slide deck is available on our website. At the end of the presentation, we will be available for Q&A. But now let's start and I hand over to Dietmar Siemssen. Dietmar?

Dietmar Siemssen
CEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division

Yes. Thank you Guido. And welcome, everybody, and thank you for joining us for this call. Yes, you have all seen the news, and they are not positive. We unfortunately had to revise our guidance for 2025. Yes, Q3 came in lower than expected. The organic revenues were 1.2% below the previous year's quarter, and the adjusted EBITDA was 9.4% below. The adjusted EBITDA margin was 18.8% and thus 1.7% lower than in the previous year's period. We won't be able to compensate this until the end of the year, even though we expect Q4 to be stronger than the third quarter. And we did not expect this development.

It is disappointing to say at least, and we clearly have to

Recommended For You

Analyst’s Disclosure:I/we have a beneficial long position in the shares of BTC-USD, ETH-USD, XAUUSD:CUR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I'm not an investment advisor.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of VICI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Peak Financial Advisors LLC initiated a new position in Oracle Corporation (ORCL 3.10%), acquiring 11,820 shares during the quarter, an estimated $3.32 million trade based on the average price for the quarter ended 2025-09-30, according to an October 8, 2025, SEC filing.

What happenedAccording to a recent SEC filing dated October 8, 2025, Peak Financial Advisors LLC disclosed a new holding in Oracle(ORCL 3.10%) totaling 11,820 shares. The estimated trade value was $3,324,257. The addition brings the fund’s total number of reportable positions to 85, with Oracle now representing 1.5620% of portfolio assets.

What else to knowNew position in Oracle; represents 1.5620% of Peak Financial Advisors LLC’s 13F reportable AUM, outside the fund’s top five holdings

Top holdings after the filing:

FLXR: $24,887,736 (11.9% of AUM)GLDM: $19.06 million (9.1% of AUM)CTA: $16.24 million (7.8% of AUM)MTBA: $15.03 million (7.2% of AUM)EMB: $7,605,340 (3.6% of AUM)As of October 7, 2025, Oracle shares were priced at $284.24, up 67.2% over the past year, outperforming the S&P 500 by 51.35 percentage points

Company OverviewMetricValuePrice (as of market close 2025-10-07)$284.24Market Capitalization$806.95 billionRevenue (TTM)$59.02 billionNet Income (TTM)$12.44 billionCompany SnapshotOffers a comprehensive suite of cloud software applications, infrastructure technologies, databases, middleware, hardware, and consulting services.

Generates revenue primarily through cloud subscriptions, software licensing, hardware sales, and related support and consulting services, leveraging both direct and indirect sales channels.

Serves a global client base including enterprises across industries, government agencies, and educational institutions seeking scalable information technology solutions.

Oracle Corporation is a global leader in enterprise software and cloud infrastructure, with a strong focus on integrated solutions for complex IT environments. The company leverages its broad product portfolio and extensive industry expertise.

Foolish takePeak Financial Advisors backed up the truck and opened a new position in Oracle during Q3 2025, picking up almost 12,000 shares valued at over $3 million. It was a big bite compared to the rest of the company’s portfolio, and while not in the top five of its holdings, Oracle immediately shot into the top 15 (out of over 80 positions).

This is a fairly strong vote of confidence for Oracle, and there are plenty of reasons for Peak Financial Advisors to be bullish on this company. A possible upcoming deal between Oracle and its partners to own a large share of TikTok and the company's massive push to build out more AI-centric infrastructure in its cloud unit give investors a lot of future-focused elements to consider. If AI is to be the next big innovation, it’s clear that Peak Financial Advisors is looking for an angle, and Oracle is certainly a solid play.

This new position definitely looks to be a bullish move on Peak Financial Advisors’ part, though it remains to be seen if the company will add to this position in the future, or simply hold out for the long run at a price point it believed to be a bargain.

Glossary13F reportable assets: Assets that institutional investment managers must disclose quarterly to the SEC if they exceed a certain threshold.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a financial institution or fund.
New position: The first time a fund or investor acquires shares in a particular company, creating a new holding in their portfolio.
Top holdings: The largest investments in a fund's portfolio, typically ranked by market value or portfolio percentage.
Outperforming: Achieving a higher return or growth rate compared to a relevant benchmark, such as the S&P 500 index.
Cloud software applications: Software accessed and operated over the internet, typically via subscription, rather than installed locally on devices.
Middleware: Software that connects different applications or systems, enabling them to communicate and share data.
Direct and indirect sales channels: Direct sales involve selling products to customers without intermediaries; indirect sales use third parties like resellers or distributors.
TTM: The 12-month period ending with the most recent quarterly report.

Kristi Waterworth has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Oracle. The Motley Fool has a disclosure policy.

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Tronox Holdings plc (NYSE: TROX) between February 12, 2025 and July 30, 2025, both dates inclusive (the “Class Period”), of the important November 3, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Tronox common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Tronox class action, go to https://rosenlegal.com/submit-form/?case_id=44403 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made statements regarding Tronox’s overall expected growth and strength in its pigment and zircon commercial division. The lawsuit alleges that defendants made overwhelmingly positive statements to investors regarding these divisions, as well as on its ability to achieve 2025 revenue growth projections, to investors while at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Tronox’s ability to forecast the demand for its pigment and zircon products or otherwise the true state of its commercial division, despite making lofty long-term projections, Tronox’s forecasting processes fell short as sales continued to decline and costs increased, ultimately, derailing Tronox’s revenue projections. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Tronox class action, go to https://rosenlegal.com/submit-form/?case_id=44403 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”), of the important October 14, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Unicycive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Unicycive class action, go to https://rosenlegal.com/submit-form/?case_id=44659 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 14, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Unicycive’s readiness and ability to satisfy the U.S. Food and Drug Administration’s (“FDA”) manufacturing compliance requirements was overstated; (2) the oxylanthanum carbunate (“OLC”) New Drug Application’s (“NDA”) regulatory prospects were likewise overstated; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Unicycive class action, go to https://rosenlegal.com/submit-form/?case_id=44659 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Analyst’s Disclosure:I/we have a beneficial long position in the shares of HPQ either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SummaryHot take of the day: buy a fund that has climbed 111% in the past six months and that appears overbought.ARKK is exposed to the themes that I believe will create substantial value over the very long run.Valuation does not matter as much, since standard metrics like next-year P/E capture expected short-term performance and do not match the long-term duration of ARKK's investments.The trick: watch moving averages to know when to pull the plug, should the recent doubling of the stock price proves to be ARKK's bubble 2.0.piranka/E+ via Getty Images

Here's a hot take for the day: buy a fund that, despite a poor five-year track record, down 9% cumulatively against the S&P 500's (SPY) 96% gains, has rallied to the stratosphere in the recent past. Oh, on a

Analyst’s Disclosure:I/we have a beneficial long position in the shares of QQQ, SPY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, announced today that it held a “Drive Home Together” co-creation ceremony for Calvin Gong, the newest FF 91 2.0 Futurist Alliance owner. The delivery took place in Bradbury, California, on October 8 and was attended by FF leadership, Including FF Founder and Global Co-CEO YT Jia and FX Global CEO Xaio (Max) Ma. Other guests included fashion model and designer Suede Brooks, who is also an FF 91 2.0 user and Developer Co-Creation Officer for the Company.

Calvin Gong is the President of Pinnacle Real Estate Group, one of the largest Chinese-American real estate brokerages in Southern California.

“Calvin is our first Co-Creation Officer since we announced the “EAI + Crypto” Dual Flywheel & Dual Bridge Eco-Strategy, making this moment especially meaningful,” said YT Jia. “Our Co-Creation Ecosystem Online Direct Sales model goes beyond selling cars, it’s about user acquisition, user co-creation, and user operations. Together with Calvin and Pinnacle, FF and FX are looking forward to building a value co-creation and sharing ecosystem that connects real estate, mobility, AI, and crypto.”

A video of the delivery ceremony can be viewed here: https://youtu.be/4I1wU94np6E

In June 2025, Faraday Future also signed a deposit agreement with Pinnacle Real Estate Group for the FX Super One, the Company’s new first class EAI-MPV. This agreement includes a non-refundable deposit and non-binding reservations for 1,000 units of the FX Super One.

This collaboration marks a first-of-its-kind global innovation: a “B2B2C” business model that brings together the AIEV and real estate sectors in a shared ecosystem. The initiative leverages Pinnacle’s expansive real estate footprint to unlock powerful synergies between smart mobility and lifestyle. Pinnacle and Calvin Gong are paid co-creation partners.

Headquartered in Southern California, Pinnacle Real Estate Group operates three branches with a total of more than 1,000 real estate agents. Its business spans a broad range of services — from residential and luxury home sales to commercial real estate investment, financing, and property management.

“I’m thrilled to become the latest FF 91 2.0 user and Co-Creation Officer for FF and can’t wait to not only get behind the wheel of this amazing vehicle but also proud to be leading the way with Faraday Future in our unique cross-industry collaboration,” said Calvin Gong. “This partnership represents a powerful new approach to how people experience both real estate and mobility.”

About Faraday Future 

Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company’s mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future’s flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit https://www.ff.com/us/. 

FORWARD LOOKING STATEMENTS

This press release includes “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding the cross-collaboration with Calvin Gong, President of Pinnacle Real Estate Group, contributions by both regarding FF and FX, FF and FX product development and delivery, and FF and FX market positioning, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.

Important factors, among others, that may affect actual results or outcomes include, among others: the Company’s ability to secure the necessary funding to execute on the FX strategy, which will be substantial; the Company’s ability to secure agreements with OEMs that are necessary to execute on the FX strategy; the number of Super Ones that Pinnacle ultimately chooses to purchase, which may be as few as one; the number of potential purchasers for the Super One that Pinnacle can identify; the Company’s ability to continue as a going concern and improve its liquidity and financial position; the Company’s ability to pay its outstanding obligations; the Company's ability to remediate its material weaknesses in internal control over financial reporting and the risks related to the restatement of previously issued consolidated financial statements; the Company’s limited operating history and the significant barriers to growth it faces; the Company’s history of losses and expectation of continued losses; the success of the Company’s payroll expense reduction plan; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the Company’s ability to cover future warranty claims; the success of other competing manufacturers; the performance and security of the Company’s vehicles; current and potential litigation involving the Company; the Company’s ability to receive funds from, satisfy the conditions precedent of and close on the various financings described elsewhere by the Company; the result of future financing efforts, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s indebtedness; the Company’s ability to cover future warranty claims; the Company’s ability to use its “at-the-market” program; insurance coverage; general economic and market conditions impacting demand for the Company’s products; potential negative impacts of a reverse stock split; potential cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; circumstances outside of the Company's control, such as natural disasters, climate change, health epidemics and pandemics, terrorist attacks, and civil unrest; risks related to the Company's operations in China; the success of the Company's remedial measures taken in response to the Special Committee findings; the Company’s dependence on its suppliers and contract manufacturer; the Company's ability to develop and protect its technologies; the Company's ability to protect against cybersecurity risks; and the ability of the Company to attract and retain employees, any adverse developments in existing legal proceedings or the initiation of new legal proceedings, and volatility of the Company’s stock price. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Form 10-K filed with the SEC on March 31, 2025, and Form 10-Q filed on August 19, 2025, and other documents filed by the Company from time to time with the SEC.

CONTACTS:
Investors (English): [email protected]
Investors (Chinese): [email protected]
Media: [email protected]

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/b32967c2-f15f-435c-ba0b-fe82c06c4d14
https://www.globenewswire.com/NewsRoom/AttachmentNg/8e99607e-88fc-4568-96e5-5c1e8e2014c4

Faraday Future Announces Pinnacle Real Estate Group President Calvin Gong Takes Delivery of His New...
Faraday Future Announces Pinnacle Real Estate Group President Calvin Gong Takes Delivery of His New...

Faraday Future Announces Pinnacle Real Estate Group President Calvin Gong Takes Delivery of His New ...
Faraday Future Announces Pinnacle Real Estate Group President Calvin Gong Takes Delivery of His New ...

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / Alaska Energy Metals Corporation (TSXV:AEMC)(OTCQB:AKEMF) ("AEMC" or the "Company") announces that it has entered into debt settlement agreements (the "Settlement Agreements") with certain insiders of the Company (the "Creditors") to settle an aggregate of $95,200 in debt (the "Debt") for services provided by the Creditors to the Company (the "Services"). In settlement and full satisfaction of the Debt in connection with the Services, the Company has agreed to issue to the Creditors an aggregate of 952,000 common shares in the capital of the Company (the "Debt Shares") at a deemed issue price of $0.10 per Debt Share (the "Debt Settlement").

By Reuters

October 10, 20254:11 AM UTCUpdated ago

A smartphone with a displayed NVIDIA logo is placed on a computer motherboard in this illustration taken March 6, 2023. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab

Oct 10 (Reuters) - China has stepped up the enforcement of its controls on chip imports, as Beijing seeks to wean the country's technology companies away from U.S. products such as Nvidia's

(NVDA.O), opens new tab artificial intelligence processors, the Financial Times reported on Friday.

Sign up here.

Reporting by Ananya Palyekar in Bengaluru; Editing by Mrigank Dhaniwala

Our Standards: The Thomson Reuters Trust Principles., opens new tab

SummaryThis October's Dividend Kings list features 56 stocks, with Kenvue and United Bankshares meeting the ideal "fair price" yield criteria.Analysts project the top-ten Dividend Kings could deliver 19.2% to 41.5% net gains by October 2026, with KVUE offering the highest upside.Only two of the top-ten Kings, KVUE and UBSI, are considered "safer" with sufficient free cash flow to cover their dividends at current prices.Investors should focus on undervalued, high-yield "dog" stocks, monitor for price pullbacks, and prioritize those with strong dividend safety metrics.“A Dividend King [is] a stock with 50 or more consecutive years of dividend increases.” - Suredividend.com.Looking for a portfolio of ideas like this one? Members of The Dividend Dog Catcher get exclusive access to our subscriber-only portfolios. Learn More »smrm1977/iStock via Getty Images

Foreword As supplement to this article, please note that The Motley Fool, which sourced this latest list, and SureDividend both update their lists periodically. Kiplinger also featured this recent selection of Kings.

Note that two Kings

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Ad hoc announcement pursuant to Art. 53 LR

NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAWS.

Idorsia successfully completes the offering of 16.4 million new and treasury shares – upsized from 15 million shares – through an accelerated bookbuilding process with gross proceeds of CHF 65.6 million

Allschwil, Switzerland – October 10, 2025
Idorsia Ltd (SIX: IDIA, “Idorsia”) announces that it has successfully raised CHF 65.6 million through the placement of 16.4 million registered shares (the “Offer Shares”) at a placement price of CHF 4.00 per share – in-line with the Volume-Weighted Average Price from the last 30 days – by way of an accelerated bookbuilding process (the “Offering”). The proceeds from the Offering strengthen Idorsia’s balance sheet and will fund the company’s disciplined investment in accelerating the commercial trajectory of QUVIVIQ and advancing a de-risked, science-driven pipeline, as well as for general corporate purposes.

Arno Groenewoud, Chief Financial Officer of Idorsia, commented:
“We are very pleased with the strong investor response and successful completion of the accelerated bookbuilding process. The oversubscribed demand from top-tier institutional investors reflects a clear recognition of Idorsia’s significant potential. The proceeds strengthen our financial position and significantly extend our cash runway, enabling us to fund our activities through to overall profitability in 2027. This milestone marks the completion of our financial turnaround since early 2025 and firmly positions us on a path toward sustainable, long-term value creation for our shareholders.”

The Offer Shares are sourced from Idorsia's capital band and issued without subscription rights to existing shareholders (12.9 million newly issued shares representing 5.45% of the approximately 236 million Idorsia shares listed on SIX prior to the transaction) as well as from treasury shares (3.5 million).

The newly issued shares are expected to be listed and admitted to trading on SIX Swiss Exchange on October 13, 2025, and will rank pari passu with the existing shares. Payment and settlement are expected to take place on October 14, 2025.

In connection with the Offering, Idorsia agreed to a 180-day lock-up period, inclusive of the equity line set up in September 2025 and due to expire at the end of March 2026. Jean-Paul and Martine Clozel, the founding shareholders of Idorsia, have each agreed to a lock-up period of 180 days after the listing of the newly issued shares, subject to customary exceptions.

Notes to the editor

About Idorsia
The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core.

Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients.

Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA).

For further information, please contact:
George Thampy
Senior Vice President, Head of Investor Relations
Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil
+41 58 844 10 10
[email protected] – [email protected] – www.idorsia.com

This press release is for information purposes only and is not intended to constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States of America, Australia, Canada, Japan, or any other jurisdiction. The securities mentioned herein have not been and will not be registered under the US Securities Act of 1933 ("Securities Act") and may not be offered or sold within the United States of America except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will be no public offering of any of Idorsia’s securities in the United States of America or in any other jurisdiction.

The offers referred to herein, when made in member states of the European Economic Area ("EEA"), are only addressed to and directed to “qualified investors” within the meaning of Article 2(e) the Prospectus Regulation ("Qualified Investors"). For these purposes, the expression "Prospectus Regulation" means Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, and includes any relevant delegated regulations.

For readers in the United Kingdom, this announcement is only being distributed to and is only directed at "qualified investors" within the meaning of the Prospectus Regulation as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 who are (i) outside the United Kingdom or (ii) investment professionals falling within Article 19(5) ("Investment professionals") of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) certain high value persons and entities who fall within Article 49(2)(a) to (d) ("High net worth companies, unincorporated associations etc.") of the Order; or (iv) any other person to whom it may lawfully be communicated (all such persons in (i) to (iv) together being referred to as "relevant persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

The offering of the securities in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial Services Act (“FinSA”) because such offering is made to professional clients within the meaning of the FinSA only. This press release does not constitute a prospectus or a similar notice within the meaning of articles 35 et seqq. or 69 of the Swiss Financial Services Act and not a prospectus under any other applicable laws , and no such prospectus has been or will be prepared for or in connection with the offering of the securities.

Information to Distributors: Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended (“MiFID II”); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the “MiFID II Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract which any “manufacturer” (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Shares have been subject to a product approval process by each underwriter established in the EEA, which has determined that the Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the “EEA Target Market Assessment”). Solely for the purposes of the product governance requirements contained within 3.2.7R of the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract which any “manufacturer” (for the purposes of the UK MIFIR Product Governance Requirements) may otherwise have with respect thereto, the Shares have been subject to a product approval process by each underwriter established in the United Kingdom, which has determined that the Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in the FCA Handbook Conduct of Business Sourcebook ("COBS"); and (ii) eligible for distribution through all distribution channels as are permitted by UK MiFIR Product Governance Requirements (the “UK Target Market Assessment” and, together with the EEA Target Market Assessment, the "Target Market Assessments"). Notwithstanding the Target Market Assessments, Distributors should note that: the price of the Shares may decline and investors could lose all or part of their investment; the Shares offer no guaranteed income and no capital protection; and an investment in the Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom.

The Target Market Assessments are without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offer. Furthermore, it is noted that, notwithstanding the Target Market Assessments, the Managers established in the EEA and the United Kingdom will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessments do not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II and/or the UK MiFIR Product Governance Requirements; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Shares and determining appropriate distribution channels.

The underwriters are acting exclusively for Idorsia and no-one else in connection with the offerings. They will not regard any other person as their respective clients in relation to the offerings and will not be responsible to anyone other than Idorsia for providing the protections afforded to their respective clients, nor for providing advice in relation to the offerings, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

This press release may contain certain forward-looking statements relating to Idorsia and its business, which can be identified by the use of forward-looking terminology such as "estimates", "believes", "expects", "may", "are expected to", "will", "will continue", "should", "would be", "seeks", "pending" or "anticipates" or similar expressions, or by discussions of strategy, plans or intentions. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Idorsia to be materially different from those expressed or implied by such statements. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. Idorsia disclaims any obligation to update any such forward-looking statements.

Press Release PDF

Bitcoin prices experienced a modest decline on October 9.

getty

Bitcoin prices dropped below $120,000 on Thursday, October 9, as several variables pushed the digital currency lower.

The world’s most prominent cryptocurrency fell to as little as $119,713.65, after rising to as much as $123,822.08 earlier in the day, according to Coinbase data from TradingView. This movement represented a 3.3% decline.

The digital asset reached a fresh, all-time high of more than $126,000 earlier this month, and has mostly been fluctuating north of $120,000 since then, additional Coinbase figures from TradingView reveal.

Profit Taking While analysts highlighted a range of variables as contributing to bitcoin’s latest declines, one theme that came up consistently was traders taking profits.

Some market observers also singled out strength in the U.S. dollar relative to other fiat currencies.

Joe DiPasquale, CEO of cryptocurrency hedge fund manager BitBull Capital, for example, was in this camp, stating via email that “Bitcoin’s recent pullback below $120,000 reflects a mix of short-term profit-taking after its record surge, risk-off sentiment across broader markets, and renewed dollar strength weighing on crypto as a hedge.”

“Weak on-chain activity has also raised questions about the durability of the rally, adding to the selling pressure,” he added.

Bitfinex analysts offered a similar take, stating via comments placed in a Google Doc that “For us, Bitcoin’s latest decline below $120,000 is driven by a mix of minor profit-taking, a short-term pullback after price appreciation -which is normal-, and dollar strength.”

“After pushing to a fresh all-time high near $126,000, many short-term holders are booking gains, which is expected,” they added.

Tom Bruni, head of markets & retail investor insights at Stocktwits, also noted the impact of traders taking profits, but also chose to highlight the effect of the upcoming earnings season.

“The pullback in Bitcoin and broader risk assets reflects profit-taking ahead of the next obvious risk factor for the markets, earnings season kicking off next week.”

“Risks from the Fed, tariffs, or other global tensions have largely been discounted in the market, but earnings remain the wildcard, keeping traders with a ‘one foot out the door’ attitude,” he continued.

Market ConsolidationTim Enneking, managing partner of Psalion, offered a different take on what drove today’s price movements, downplaying the impact of profit taking and the U.S. dollar.

Instead, he described bitcoin’s recent price movements as being price consolidation that was modestly impacted by news that Luxembourg has invested 1% of its sovereign wealth fund into the digital asset.

While the nation’s government released an announcement stating that the fund had invested in cryptocurrencies, media reports from both CoinDesk and Decrypt indicated that it had put money into bitcoin exchange-traded funds.

Enneking spoke to this development, stating via email that “Today was a little bit more than continued consolidation around $120k because of the announcement out of Luxembourg: 1% of its sovereign wealth fund will be invested in BTC.”

“That caused a bit of an upward move timed with the NY equities open, but, while positive news, it’s hardly massive,” he continued.

“So, the market quickly digested that tidbit, and continued its consolidation with a slight negative trajectory. It would be a mistake to read too much into it,” he concluded.

Bitcoin is entering a dominant new era powered by global liquidity, as easing from the U.S. and China replaces outdated cycles—an inflection point Arthur Hayes underscores.

The Ripple XRP is quietly executing a mission of its own, transforming the global financial plumbing from the inside out. By moving beyond theory and into practical application, XRP technology is being adopted by banks, payment networks, and central institutions seeking faster and more efficient cross-border transfers.

XRP As The Bridge Between Old And New Finance
While most of the crypto world obsesses over price swings and short-term narratives, Ripple is quietly executing on something much larger: a structural rewrite of global finance. As Xfinancebul pointed out on X, XRP isn’t here to compete with other cryptocurrencies. It’s here to replace the old system that still underpins international payments today.

Thunes and Ripple’s relationship is a prime example of this transformation in motion. Together, they connect over 130 countries and tap into more than 90% of the global foreign exchange (FX) markets, effectively stitching together a new global settlement network powered by XRP. 

Combined, these two powerhouses are actively unlocking real-time settlement, establishing vital liquidity corridors, and pushing enterprise-grade blockchain integration onto a global stage. Thus, the numbers are powering over $70 billion in annual payment volume, spanning multiple currencies. 

However, while most crypto communities have remained fixated on price charts and short-term gains, Ripple has engaged in collaboration. The firm is working directly with banks, navigating complex regulatory landscapes, and integrating with global networks to fix the speed, cost, and transparency that the SWIFT system has been struggling with.

Xfinancebul highlighted that this profound utility validates everything XRP has always stood for. XRP is not just another token, but a foundation piece of digital finance that is now seeing adoption at an accelerating scale within the institutional level.

The game truly changes when liquidity begins to flow seamlessly through XRP, instead of being bogged down by legacy rails. This isn’t just a minor improvement for payments, but a paradigm shift for the entire global financial ecosystem. 

Digital Asset That Refuses To Slow Down
An analyst known as Ripple Track has also emphasized that XRP is engineered for speed, institutional trust, and a tool for future global financial transformation. Presently, that future is already starting to echo through the charts. 

Other XRP-related coins have been exhibiting bullish action in the last few days. After rallying from $0.04 to new all-time highs in mere days last year, XRPH is once again forming the same explosive setup. 

In the meantime, XRP Healthcare (XRPH), a token in the Ripple ecosystem, is coiling like a spring, with pressure building steadily, momentum rising to the surface, and the charts screaming ready to launch. “History doesn’t repeat itself, but when it rhymes out loud, the wise listen,” the analyst mentioned.

XRP trading at $2.81 on the 1D chart | Source: XRPUSDT on Tradingview.com
Featured image from Adobe Stock, chart from Tradingview.com

Leading cryptocurrencies fell alongside stocks on Thursday, as investors reduced their risk appetite amid the government shutdown. Cryptocurrency Gains +/- Price (Recorded at 9:30 p.m.

Monero's ‘Fluorine Fermi' update enhances privacy by fighting nodes that try to link user IP addresses to their transactions.

2 mins mins

Key Points:

Yi He of Binance hints at future BNB Chain support for diverse wallets.Statement highlights ongoing U.S. regulatory compliance issues.Potential shifts in market conditions due to expanded accessibility.
On October 10th, Binance co-founder He Yi confirmed via social media that Binance will cease serving American users due to policy restrictions, impacting the BNB Chain ecosystem.

This decision could limit accessibility for American investors, affecting BNB Chain’s global reach and the potential involvement in Meme Token projects outside Binance’s native wallet system.

Binance Eyes Expanded Wallet Support Amid U.S. Regulatory Hurdles
Binance’s potential expansion signifies an adaptation to broader user demands and regulatory landscapes. It could signal a strategic shift to foster inclusivity across its BNB Chain, thus potentially increasing its interoperability and market reach, despite ongoing policy challenges in serving Americans.

“Something big is coming,” said Yi He, strengthening the speculation about the potential impacts and Binance’s commitment to innovation.

“Something big is coming,” said Yi He, strengthening the speculation about the potential impacts and Binance’s commitment to innovation.
BNB Chain Strengthens Position with Broader Market Engagement
Did you know? Binance has been at the forefront of blockchain innovation, continually adapting to market demands and regulatory environments.

Insights from Root Data Crypto suggest that Binance’s move may offer financial opportunities through new user engagement and technological integration. However, regulatory challenges must be navigated carefully. An expanded ecosystem could bolster liquidity and development across the BNB Chain, fostering broader network activity.

BNB(BNB), daily chart, screenshot on CoinMarketCap at 02:25 UTC on October 10, 2025. Source: CoinMarketCap

https://x.com/ourcryptotalk

DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.

Rate this post

Dogecoin’s spot pair is grinding higher inside a well-defined structure while its BTC cross sits at an inflection between monthly moving averages—an alignment three widely followed traders say still favors upside, provided trend supports hold.

Is It Too Late To Buy Dogecoin?
IncomeSharks’ daily chart frames the current advance as a rising channel that has been in place since early summer. Price is riding a sequence of higher lows off the June base and is now near $0.26, mid-channel, with the lower trendline rising through roughly $0.24 and the upper boundary capping rallies in the $0.33 area.

Dogecoin price analysis | Source: X @IncomeSharks
The analyst’s “squiggle” path predicted a shallow pullback to the midline followed by a drive toward the channel top, an outlook backed by an On-Balance Volume line that continues to stair-step higher along its own rising trend. In this read, $0.24 is the pivotal dynamic support; losing it would hand control back to sellers and force a reassessment of the entire channel, while holds above $0.26 reopen a test of the $0.33 line that has repeatedly capped advances.

Cantonese Cat’s daily view focuses on market structure rather than indicators. The chart traces a long, clean downtrend line from last year’s lower-high sequence—connecting the $0.48 peak through multiple failure points—now broken and back-tested. Spot is fluctuating around $0.25–$0.26 after reclaiming that diagonal, which turns prior resistance into support.

Dogecoin trendline backtest is still valid | Source: X @cantonmeow
“It’ll never make sense to me why people kept saying that the cycle’s over and $DOGE is done when it’s making higher lows,” the trader writes, pointing to the serial HLs that have persisted since spring. If that staircase holds, the path of least resistance runs toward the prior local highs near $0.31, where supply rejected price in September; acceptance above that shelf would align with IncomeSharks’ channel targets.

DOGE Vs. BTC
The third lens is relative performance. Degentrading highlights DOGE/BTC as their “highest conviction trade,” adding color on why: “$doge has liquidity (so in the event I’m wrong, I don’t get raped on the way out). IF we get a breakout in BTC, Doge has historically performed extremely well. Out of all the dino coins, it is one that is also most familiar w tradfi. Seasonally, Oct is the month with the best median and decent mean returns for $doge… only negative year was in 2018.”

The monthly DOGE/BTC chart shows price near 0.00000204 BTC, wedged between the 7-month moving average at ~0.00000187 BTC and the 25-month moving average at ~0.00000223 BTC. That places the pair at a decision point: sustained closes above the longer MA would mark a momentum shift back toward bulls and clear the way to test stepped resistance levels printed on the chart around 0.00000231 BTC and then the mid-range clusters near 0.00000511–0.00000791 BTC, whereas rejection keeps the cross confined to its post-2024 base.

The historical blow-off high on the panel—0.00001287 BTC—illustrates the headroom if a full relative rotation develops, but the moving-average shelf is the near-term arbiter.

DOGE/BTC analysis | Source: X @degentradingLSD
Across all three takes, the through-line is that Dogecoin has not broken its constructive pattern. The spot chart continues to respect a rising channel with improving OBV, the longer downtrend has been breached and retested with HLs intact, and the BTC pair sits one push below a higher-timeframe moving-average reclaim that would confirm relative strength.

None of the analysts claim inevitability; each view anchors risk at visible levels. For spot traders, the rising lower boundary around $0.24 is the line that converts a healthy uptrend into distribution if lost; for relative-value traders, the 7-month average near 0.00000187 BTC plays the same role. As long as those floors hold, the evidence presented by IncomeSharks, Cantonese Cat, and Degentrading says it is not “too late,” but rather still about execution around the channel midline and the MA reclaim that would validate the next leg.

At press time, DOGE traded at $0.248.

DOGE needs to break the 0.382 Fib, 1-day chart | Source: DOGEUSDT on TradingView.com
Featured image created with DALL.E, chart from TradingView.com

Journalist

Posted: October 10, 2025

Key Takeaways
Why is Bitcoin’s Open Interest declining despite price stability?
Open Interest dropped nearly 8% as traders closed leveraged positions, signaling growing caution and reduced market confidence.

What do the on-chain metrics suggest about Bitcoin’s next move?
Dominant taker selling, negative NVT, and –247% DAA divergence point to short-term consolidation before recovery.

Bitcoin’s [BTC] Open Interest (OI) on Binance has dropped nearly 8% within three days after peaking at $15.07 billion, signaling traders are cutting back leveraged positions amid heightened volatility. 

BTC’s market cap dropped to approximately $13.88 billion after briefly surging to $125K before retreating to near $122K, at press time.

This shift signals fading enthusiasm after weeks of aggressive buying.

Such patterns are common after strong rallies and suggest that traders are turning cautious, favoring stability over risk as the market reacts to recent price momentum.

Spot Taker CVD hints…
Bitcoin’s Spot Taker CVD (90-day) shows strong Taker Sell dominance, confirming sellers currently control short-term price direction. 

This reflects increased market-side sell activity and weakening buyer aggression. Typically, when selling dominates for prolonged periods, it suggests fading bullish conviction and limited spot demand. 

However, this also clears excess leverage, allowing the market to reset.

The continued dominance of sellers implies that Bitcoin could face short-term price resistance, although a sudden shift in taker behavior could quickly reverse the current momentum.

NVT Golden Cross falls! 
The NVT Golden Cross has fallen to –1.24, at press time, representing a steep 59% decline, signaling weakening transaction value relative to Bitcoin’s market capitalization. Such a dip typically suggests slowing network activity during consolidation phases. 

Historically, negative NVT readings align with oversold or undervalued zones that precede eventual recoveries. However, persistent declines below this level often indicate reduced on-chain strength. 

This metric, therefore, highlights a cooling sentiment across the network, showing that recent price growth lacks strong transactional backing from new inflows.

Bitcoin’s weak network validation
At the time of writing, Bitcoin’s Price–DAA Divergence sat around –247%, revealing that price gains are not supported by active address growth. This negative divergence indicates speculative-driven price action rather than organic user expansion. 

Such divergences often precede local corrections when participation fails to confirm rallies. However, strong network recovery can quickly reverse this imbalance. 

The deep DAA divergence suggests Bitcoin’s uptrend is losing fundamental strength, increasing the likelihood of near-term consolidation as traders await renewed on-chain activity.

Conclusively, declining OI, dominant taker selling, and weak network metrics suggest that Bitcoin is cooling after its recent surge.

However, historical patterns show such phases often act as reset points before renewed bullish momentum emerges.

YZi Labs, the rebranded venture arm of crypto exchange Binance, has unveiled a $1 billion fund aimed at supporting projects on the BNB Chain, signaling a renewed focus on innovation, decentralized finance (DeFi), real-world assets (RWAs), artificial intelligence (AI), and blockchain infrastructure. The fund, named the BNB Builder Fund, aims to provide financial backing and strategic support to developers, startups, and ecosystem participants building on one of the leading blockchain platforms.

In brief
Solana daily transactions fell to 64 million, down nearly 50% from July's peak.
Capital rotation to rivals and network friction are key reasons for the decline, one expert said.
Despite a likely ETF approval Friday, Solana’s price is expected to follow Bitcoin's lead.
Solana's daily transactions are on a steady decline, even as the highly anticipated exchange-traded fund deadline arrives, with one analyst suggesting the token’s price action is likely to seek cues from Bitcoin’s directional bias.

The number of daily transactions on the network has plummeted from a peak of 125 million on July 24, 2025, to roughly 64 million, per CryptoQuant data.

The SEC’s final deadline to rule on spot Solana ETF filings from issuers including VanEck, 21Shares, Bitwise, and Franklin is on Friday, according to Bloomberg Intelligence data compiled by Eric Balchunas.

“It suggests a rebalancing away from hype volume.”  Shivam Thakral, CEO of Indian crypto exchange BuyUcoin, told Decrypt.

Thakral explained that subsiding retail activity and capital rotation into competitors like BNB Chain are the key drivers behind the drop. 

“Underneath both, any friction in validator performance or UX acts like a catalyst for decline, he added. “So, the drop is part normalization, part competitive pressure, and part sentiment shift.” 

With the U.S. Securities and Exchange Commission greenlighting “generic listing standards” in September, the specific 19b-4 filings and their deadlines have become largely irrelevant, Decrypt previously reported. 

ETF analyst Eric Balchunas previously noted that the Solana ETF approval is all but confirmed in a September 30 tweet. 

The confidence is reflected in Bitwise’s amended Wednesday filing that notes a low fee of 0.20%.

“Bitwise not playing around,” Balchunas posted in a Thursday tweet, responding to the fee structure change from Bitwise. 

“Low fees have a near-perfect record of attracting investors, so it's a good sign for inflow potential,” he added.

“Solana is unlikely to break out solo,” Thakral noted, commenting on the token’s price action. “It’s far more likely to tag along with Bitcoin’s direction.” 

A sustained bullish move would likely require a combination of broad ETF-driven inflows and a Solana-specific catalyst.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.